Aligning #cancer treatment to patient specific tumour characteristics, the JGH Foundation | Fondation HGJ has launched a project striving to implement #precisionmedicine in Canada. We are pleased to take part in the project which will improve patient selection & treatment radiomics.bio/news/press/pil…

EUCAIM has released its data sharing platform, aiming to achieve more precise and faster clinical decision-making, diagnostics, #treatments and predictive medicine for #cancer patients. To find out more about the project click here cancerimage.eu/eucaim-unveils…

#EUCAIM has launched their first platform release on Friday. Have you checked it out already? 🤝 Do not miss it out! ➡️cancerimage.eu

Did you know almost 9 out of 10 clinical trials in #oncology fail? Radiomics believes we can partner to invert these results by extracting actionable insights from clinical trials for personalised drug development trajectories. Meet us at booth 710 at #ESMO23 to find out more!

Book a meeting with the team here, or just drop by booth 710! calendly.com/radiomics/esmo…

Our Grants Manager, Inês Pinho, just joined forces with 20+ partners in Rotterdam for the EuCanImage consortium meeting. The project is changing the game in oncology with a secure cancer imaging platform to amplify the use of AI in cancer research! #EuCanImage #CancerResearch #AI

The #ESMO23 Conference has been an incredible ride, filled with groundbreaking ideas, knowledge & expertise. The connections made & innovations witnessed at this event have us eager to drive progress in this field & continue to push the boundaries in the fight against #cancer!

Back on the road again! The Radiomics.bio team will be at #SITC23 this week in San Diego, ready to contribute to the evolution of cancer treatment, exploring the latest breakthroughs and engaging with industry innovators.

Excited for RSNA's Annual Meeting this week! Join Hanif Gabrani-Juma, Business Manager, as we delve into cutting-edge radiology innovation, spotlighting advancements like #radiomics & #AI. Discover how these technologies enhance outcome prediction, image analysis, and more!

1️⃣1️⃣ brilliant Walloon companies have been selected for pitching at the HealthTech Investor Summit. Will you also join us in Bruges on December 4-6 to meet investors and entrepreneurs all around Europe?

Join us at #ESMOImmuno23 in Geneva, Switzerland, Dec 6th-8th! Discover how Radiomics.bio, alongside iOnctura, are advancing precision in immunotherapy for personalised cancer treatment. Unlock the full potential of therapeutics by tailoring treatments to the patient.

Don't miss your chance to meet with Carlos Meca and Daiana Ilies for insightful discussions on the future of cancer treatment. To read to full abstract, click here cslide.ctimeetingtech.com/immuno23hybrid…

👥 Did you miss Dealflow.eu's 2023 e-pitching events? 🚀 We met 33 ground-breaking 🇪🇺 EU-funded startups from various sectors: ● #Biotech ● #Blockchain ● AI-ML ● Female-led ● #HealthTech ● Spin-offs 📢 Register on our website to join us as an #investor or #startup!

Join us on #WorldCancerDay as we stand in solidarity with all those impacted by cancer. At @Radiomics_bio, we're dedicated to propelling clinical research forward, providing vital insights to fuel the fight against cancer. #closethegap #worldcancerday #radiomics #cancerresearch

Rare is many. Rare is strong. Rare is proud. Today, we stand together in support of the broader community. Join us in amplifying the needs of people living with rare diseases. #RareDiseaseDay

Conversations sparked. Connections made. More than 45,000 attendees came together at #ASCO24 to explore the art & science of oncology and left inspired to change the future of cancer care. Thanks to all who joined us! Save the date for #ASCO25: May 30–June 3, 2025

Dr Maciej Bobowicz of Gdański Uniwersytet Medyczny (GUMed) shared with us the goals of the #EuCanImage project! Check out the video: youtube.com/watch?v=-Ff50n…

Wonderful presentation on radiomics/AI models to predict the risk of lung toxicity after CRT and durva by ⁦Jarushka Naidoo⁩ ⁦radiomics.bio⁩ #ESMO2024

Today we are providing a clinical update on #roginolisib: 👉 Clinical activity and long-term safety for our unique allosteric modulator of PI3Kδ 👉 Patients with uveal melanoma doubled OS compared to historical controls 👉 Site activation ongoing for PII

Ready to explore the future of cancer diagnostics? Join us at #ECR2025 for "The #EUCAIM Project: Building an AI-Driven Future for Cancer Diagnostics". The session will explore the transformative potential of EUCAIM’s digital imaging infrastructure in revolutionising cancer care